Profund Advisors LLC Acquires 84,207 Shares of Perrigo Company plc $PRGO

Profund Advisors LLC boosted its holdings in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 288.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 113,418 shares of the company’s stock after acquiring an additional 84,207 shares during the period. Profund Advisors LLC owned 0.08% of Perrigo worth $1,674,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. KBC Group NV increased its stake in shares of Perrigo by 61.3% during the first quarter. KBC Group NV now owns 6,283 shares of the company’s stock valued at $67,000 after purchasing an additional 2,388 shares in the last quarter. Parvin Asset Management LLC purchased a new stake in shares of Perrigo in the 2nd quarter worth approximately $79,000. Allworth Financial LP increased its position in Perrigo by 489.1% during the 2nd quarter. Allworth Financial LP now owns 9,390 shares of the company’s stock valued at $98,000 after buying an additional 7,796 shares in the last quarter. Whitebox Advisors LLC bought a new position in Perrigo during the 1st quarter valued at approximately $111,000. Finally, Integrated Wealth Concepts LLC purchased a new position in Perrigo during the second quarter valued at $126,000. Institutional investors own 95.91% of the company’s stock.

Wall Street Analysts Forecast Growth

PRGO has been the topic of a number of recent research reports. Canaccord Genuity Group increased their target price on Perrigo from $17.00 to $19.00 and gave the stock a “buy” rating in a research note on Friday. Wall Street Zen cut shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Saturday. Weiss Ratings raised shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research report on Thursday, August 6th. Finally, Zacks Research lowered shares of Perrigo from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 29th. One investment analyst has rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and a consensus target price of $18.50.

View Our Latest Report on PRGO

Perrigo Price Performance

Shares of PRGO opened at $15.81 on Tuesday. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $20.65. The company has a market capitalization of $2.19 billion, a P/E ratio of -1.26, a price-to-earnings-growth ratio of 1.83 and a beta of 0.69. The firm has a 50 day moving average of $14.86 and a 200 day moving average of $12.48. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31.

Perrigo (NYSE:PRGO – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the prior year, the firm posted ($0.06) EPS. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities research analysts anticipate that Perrigo Company plc will post 2.17 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Friday, November 27th will be paid a $0.29 dividend. The ex-dividend date is Friday, November 27th. This represents a $1.16 annualized dividend and a dividend yield of 7.3%. Perrigo’s payout ratio is currently -9.27%.

About Perrigo

(Free Report)

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.

Further Reading

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.